Development of formulations for protein drugs requiring high dosing (in the order of mg/kg) may become challenging for solubility limited proteins and for the subcutaneous (SC) route with <1.5 mL allowable administration volume that requires >100 mg/mL protein concentrations. Development of high pro
✦ LIBER ✦
Challenges for the development of therapeutic protein formulations
✍ Scribed by R. Müller
- Book ID
- 103849640
- Publisher
- Elsevier
- Year
- 2009
- Tongue
- English
- Weight
- 51 KB
- Volume
- 25
- Category
- Article
- ISSN
- 1871-6784
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Challenges in the development of high pr
✍
Steven J. Shire; Zahra Shahrokh; Jun Liu
📂
Article
📅
2004
🏛
John Wiley and Sons
🌐
English
⚖ 197 KB
Engineering challenges of protein formul
✍
Theodore W. Randolph; John F. Carpenter
📂
Article
📅
2007
🏛
American Institute of Chemical Engineers
🌐
English
⚖ 114 KB
👁 2 views
Formulations for delivery of therapeutic
✍
Snjezana Stolnik; Kevin Shakesheff
📂
Article
📅
2008
🏛
Springer Netherlands
🌐
English
⚖ 281 KB
Challenges in Development of Targeted Li
✍
Rupa R. Sawant; Vladimir P. Torchilin
📂
Article
📅
2012
🏛
American Association of Pharmaceutical Scientists
🌐
English
⚖ 393 KB
The use of flow cytometry for the detect
✍
Henryk Mach; Akhilesh Bhambhani; Brian K. Meyer; Steven Burek; Harrison Davis; J
📂
Article
📅
2011
🏛
John Wiley and Sons
🌐
English
⚖ 261 KB
👁 1 views
The amount, identity, and size distribution of particles in parenteral therapeutic protein formulations are of immense interest due to potential safety and efficacy-related implications. In this communication, we describe the use of a flow cytometer equipped with forward- and side-scattering as well
Development of Stable Influenza Vaccine
✍
J-P. Amorij; A. Huckriede; J. Wilschut; H. W. Frijlink; W. L. J. Hinrichs
📂
Article
📅
2008
🏛
Springer US
🌐
English
⚖ 598 KB